Your browser doesn't support javascript.
loading
Association Analysis of the MHC in Lupus Nephritis.
Xu, Ricong; Li, Qibin; Liu, Rongjun; Shen, Juan; Li, Ming; Zhao, Minghui; Wang, Meng; Liao, Qijun; Mao, Haiping; Li, Zhijian; Zhou, Na; Yin, Peiran; Li, Yue; Tang, Xueqing; Wu, Tian; Zhong, Zhong; Wang, Yan; Ai, Zhen; Wang, Ou; Chen, Nan; Yang, Xiaoqin; Fang, Junbin; Fu, Ping; Gu, Jieruo; Ye, Kun; Chen, Jian; Dai, Lie; Liu, Huafeng; Liu, Zhangsuo; Liao, Yunhua; Wan, Jianxin; Ding, Guohua; Zhao, Jinghong; Zhang, Hao; Fu, Shuxia; Sun, Liangdan; Zhang, Xuejun; Yang, Huanming; Wang, Jian; Wang, Jun; Liu, Jianjun; Li, Yingrui; Yu, Xueqing.
Afiliação
  • Xu R; Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Key Laboratory of Nephrology, Ministry of Health, Guangzhou, Guangdong, China.
  • Li Q; Department of Nephrology, Shenzhen Second People's Hospital and the First Affiliated Hospital of Shenzhen University, Shenzhen, China.
  • Liu R; BGI Genomics, BGI-Shenzhen, Shenzhen, China.
  • Shen J; Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Key Laboratory of Nephrology, Ministry of Health, Guangzhou, Guangdong, China.
  • Li M; Nephrology and Rheumatology Department, Guangzhou Panyu Central Hospital, Guangzhou, Guangdong, China.
  • Zhao M; BGI Genomics, BGI-Shenzhen, Shenzhen, China.
  • Wang M; Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Key Laboratory of Nephrology, Ministry of Health, Guangzhou, Guangdong, China.
  • Liao Q; Renal Division, Peking University First Hospital, Peking University, Institute of Nephrology, Beijing, China.
  • Mao H; Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Key Laboratory of Nephrology, Ministry of Health, Guangzhou, Guangdong, China.
  • Li Z; BGI Genomics, BGI-Shenzhen, Shenzhen, China.
  • Zhou N; Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Key Laboratory of Nephrology, Ministry of Health, Guangzhou, Guangdong, China.
  • Yin P; Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Key Laboratory of Nephrology, Ministry of Health, Guangzhou, Guangdong, China.
  • Li Y; BGI Genomics, BGI-Shenzhen, Shenzhen, China.
  • Tang X; Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Key Laboratory of Nephrology, Ministry of Health, Guangzhou, Guangdong, China.
  • Wu T; BGI Genomics, BGI-Shenzhen, Shenzhen, China.
  • Zhong Z; Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Key Laboratory of Nephrology, Ministry of Health, Guangzhou, Guangdong, China.
  • Wang Y; BGI Genomics, BGI-Shenzhen, Shenzhen, China.
  • Ai Z; Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Key Laboratory of Nephrology, Ministry of Health, Guangzhou, Guangdong, China.
  • Wang O; BGI Genomics, BGI-Shenzhen, Shenzhen, China.
  • Chen N; Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Key Laboratory of Nephrology, Ministry of Health, Guangzhou, Guangdong, China.
  • Yang X; BGI Genomics, BGI-Shenzhen, Shenzhen, China.
  • Fang J; Department of Nephrology, Rui Jin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Fu P; BGI Genomics, BGI-Shenzhen, Shenzhen, China.
  • Gu J; BGI Genomics, BGI-Shenzhen, Shenzhen, China.
  • Ye K; Department of Nephrology, West China School of Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Chen J; Department of Rheumatology, The Third Affiliated Hospital and.
  • Dai L; Department of Nephrology, The People's Hospital of Guangxi Autonomous Region, Nanning, Guangxi, China.
  • Liu H; Department of Nephrology, Fuzhou General Hospital of Nanjing Military Command, Fuzhou, Fujian, China.
  • Liu Z; Department of Rheumatology and Clinical Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Liao Y; Institute of Nephrology, Guangdong Medical University, Zhanjiang, Guangdong, China.
  • Wan J; Department of Nephrology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
  • Ding G; Department of Nephrology, The First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, China.
  • Zhao J; Department of Nephrology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China.
  • Zhang H; Department of Nephrology, Renmin Hospital, Wuhan University, Wuhan, Hubei, China.
  • Fu S; Department of Nephrology, Xinqiao Hospital, The Third Military Medical University, Chongqing, China.
  • Sun L; Department of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Zhang X; Department of Nephrology, The Second Hospital, Hebei Medical University, Shijiazhuang, Hebei, China.
  • Yang H; Institute of Dermatology and Department of Dermatology, No. 1 Hospital and.
  • Wang J; Collaborative Innovation Center of Complex and Severe Skin Disease, Anhui Medical University, Hefei, Anhui, China.
  • Wang J; Collaborative Innovation Center of Complex and Severe Skin Disease, Anhui Medical University, Hefei, Anhui, China.
  • Liu J; Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
  • Li Y; BGI Genomics, BGI-Shenzhen, Shenzhen, China.
  • Yu X; James D. Watson Institute of Genome Sciences, Hangzhou, China.
J Am Soc Nephrol ; 28(11): 3383-3394, 2017 Nov.
Article em En | MEDLINE | ID: mdl-28754791
ABSTRACT
Lupus nephritis (LN) is one of the most prevalent and serious complications of SLE, with significant effects on patient and renal survival. Although a large number of genetic variants associated with SLE have been identified, biomarkers that correlate with LN are extremely limited. In this study, we performed a comprehensive sequencing analysis of the whole MHC region in 1331 patients with LN and 1296 healthy controls and validated the independent associations in another 950 patients with LN and 1000 controls. We discovered five independent risk variants for LN within the MHC region, including HLA-DRß1 amino acid 11 (Pomnibus<0.001), HLA-DQß1 amino acid 45 (P<0.001; odds ratio, 0.58; 95% confidence interval, 0.52 to 0.65), HLA-A amino acid 156 (Pomnibus<0.001), HLA-DPß1 amino acid 76 (Pomnibus<0.001), and a missense variant in PRRC2A (rs114580964; P<0.001; odds ratio, 0.38; 95% confidence interval, 0.30 to 0.49) at genome-wide significance. These data implicate aberrant peptide presentation by MHC classes 1 and 2 molecules and sex hormone modulation in the development of LN.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nefrite Lúpica / Estudo de Associação Genômica Ampla / Complexo Principal de Histocompatibilidade Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: J Am Soc Nephrol Assunto da revista: NEFROLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nefrite Lúpica / Estudo de Associação Genômica Ampla / Complexo Principal de Histocompatibilidade Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: J Am Soc Nephrol Assunto da revista: NEFROLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China